Evidence map›Paper›PMID 25834816›Full record

ArticleBioMed research international2015

A functional variant at miR-520a binding site in PIK3CA alters susceptibility to colorectal cancer in a Chinese Han population.

Lifang Ding, Zao Jiang, Qiaoyun Chen, Rong Qin, Yue Fang, Hao Li

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. mirSNPs as Potential Colorectal Cancer Biomarkers: A Systematic Review.International journal of molecular sciences · 2024
    Pooled it
  2. Pooled it
  3. The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2022
    Article
  4. Review
  5. Article
  6. Expression of miR-551b and its effect on apoptosis in human gastric carcinoma.International journal of clinical and experimental pathology · 2018
    Article
  7. Article
  8. Article
  9. Genetic variationOncoTargets and therapy · 2016
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Lifang DingDepartment of Oncology, Danyang People's Hospital, Danyang 213000, China ; Department of Oncology, Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China.
Zao JiangDepartment of Oncology, Affiliated Zhongda Hospital of Southeast University, Nanjing 210009, China.
Qiaoyun ChenDepartment of Central Laboratory, Affiliated People's Hospital of Jiangsu University, Zhenjiang 212002, China.
Rong QinDepartment of Oncology, Affiliated People's Hospital of Jiangsu University, Zhenjiang 212002, China.
Yue FangDepartment of Central Laboratory, Affiliated People's Hospital of Jiangsu University, Zhenjiang 212002, China.
Hao LiDepartment of Clinical Laboratory, Taixing People's Hospital, Taixing 225400, China.ORCID 0000-0002-5219-7234
Jiangsu University · CNFuyang City People's Hospital · CNTaixing People's Hospital · CNZhongda Hospital Southeast University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An increasing body of evidence has indicated that polymorphisms in the miRNA binding site of target gene can alter the ability of miRNAs to bind their target genes and modulate the risk of cancer. We aimed to investigate the association between a miR-520a binding site polymorphism rs141178472 in the PIK3CA 3'-UTR and the risk of colorectal cancer (CRC) in a Chinese Han population. The polymorphism rs141178472 was analyzed in a case-control study, including 386 CRC patients and 394 age- and sex-matched controls; the relationship between the polymorphism and the risk of colorectal cancer was examined. Individuals carrying the rs141178472 CC genotype or C allele had an increased risk of developing CRC (CC versus TT, OR (95% CI): 1.716 (1.084-2.716), P = 0.022; C versus T, OR (95% CI): 1.258 (1.021-1.551), P = 0.033). Furthermore, the expression of PIK3CA was detected in the peripheral blood mononucleated cell of CRC patients, suggesting that mRNA levels of PIK3CA might be associated with SNP rs141178472. These findings provide evidence that a miR-520a binding site polymorphism rs141178472 in the PIK3CA 3'-UTR may play a role in the etiology of CRC.

Indexed as

AdultAgedBinding SitesCase-Control StudiesChinaClass I Phosphatidylinositol 3-KinasesColorectal NeoplasmsFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenotypeHumansMaleMicroRNAsMiddle AgedPhosphatidylinositol 3-KinasesClass I Phosphatidylinositol 3-KinasesMicroRNAsMIRN520 microRNA, humanPhosphatidylinositol 3-KinasesPIK3CA protein, humanRNA, Messenger

Identifiers

PMID25834816
PMCPMC4365313
OpenAlexW2056602374

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.